Andere Sprachen Towa Pharmaceutical Co., Ltd.

Aktien

891725

JP3623150004

4553

Markt geschlossen - Japan Exchange Andere Börsenplätze 08:00:00 28.06.2024			% 5 Tage	% 1. Jan.
2 939 ^JPY	+0,27 %		+2,69 %	+24,96 %

26.06.	Towa Pharmaceutical gibt Aktien als eingeschränkte Vergütung an Direktoren aus	MT
06.06.	Luye Pharmas japanischer Partner Towa reicht neuen Arzneimittelantrag für Demenzpflaster ein	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Towa Pharmaceutical Issues Shares as Restricted Compensation to Directors	26.06.
Luye Pharma's Japanese Partner Towa Files New Drug Application for Dementia Patch	06.06.
Towa Pharmaceutical Co., Ltd. Files New Drug Application to the Ministry of Health, Labour and Welfare in Japan for the Rivastigmine Twice Weekly Transdermal Patch for Treating Mild to Moderate Dementia Associated with Alzheimer's Disease	06.06.
Towa Pharmaceutical Co., Ltd. Announces Board and Committee Resignations	22.05.
Towa Pharmaceutical Completes Payment for Director Stock Compensation	25.03.
VIE STYLE, Inc. announced that it has received ¥305 million in funding from Otsuka Holdings Co., Ltd., KAYAC Inc., Taisho Pharmaceutical Holdings Co., Ltd., Towa Pharmaceutical Co., Ltd., PE&HR Co., Ltd., Murata Manufacturing Co., Ltd. and other investors	07.03.
Towa Pharmaceutical : FY2023(1st quarter) Summary of Consolidated Financial Results for the Three Months Ended June 30, 2023(Based on Japanese GAAP) (375K/7P)	10.08.23
Towa Pharmaceutical : FY2023(1st quarter) Supplementary Material of Financial Results (1.03M/28P)	10.08.23
Towa Pharmaceutical : Notice of the 67th Ordinary General Meeting of Shareholders （176KB／10P）	31.05.23
Towa Pharmaceutical : FY2022 Supplementary Material of Financial Results (1.2M/42P)	15.05.23
Towa Pharmaceutical : FY2022(4th quarter) Summary of Consolidated Financial Results for the Year Ended March 31, 2023(Based on Japanese GAAP) (616K/10P)	15.05.23
Towa Pharmaceutical : 2023年3月期決算短信〔日本基準〕（連結）	15.05.23
Towa Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	15.05.23
Chugai and Towa Launch Edirol Tablet for Osteoporosis Treatment	09.12.22
Towa Pharmaceutical Co., Ltd. completed the acquisition of Sunsho Pharmaceutical Co., Ltd. from Carlyle Japan Partners III, a fund managed by The Carlyle Group Inc. (NasdaqGS:CG).	07.03.22
TOWA PHARMACEUTICAL : INTEGRATED REPORT 2021	21.12.21
Towa Pharmaceutical Co., Ltd. agreed to acquire Sunsho Pharmaceutical Co., Ltd. from Carlyle Japan Partners III, a fund managed by The Carlyle Group Inc. (NasdaqGS:CG) for ¥47.7 billion.	17.12.21
Chugai - Towa Pharmaceutical Receives Approval for Authorized Generic Version of Chugai's Osteoporosis Agent Edirol	06.12.21
Protosera, Inc. announced that it expects to receive funding from Towa Pharmaceutical Co., Ltd.	24.03.21
Luye Pharma : Strikes Licensing Deal with Japan's Towa Pharma for Alzheimer's Disease Drug	18.02.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Towa Pharmaceutical Co., Ltd.

Aktien

891725

JP3623150004

4553

Andere Sprachen

Filter